ENHANCED BIMATOPROST OPHTHALMIC SOLUTION

A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein. A method which is useful in treating glaucoma or ocular hyperten...

Full description

Saved in:
Bibliographic Details
Main Authors Chang-Lin Joan-En, Chang James N, Jordan R. Scott, Chang Chin-Ming, Schiffman Rhett M
Format Patent
LanguageEnglish
Published 01.09.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein. A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein.
AbstractList A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein. A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein.
Author Schiffman Rhett M
Jordan R. Scott
Chang Chin-Ming
Chang-Lin Joan-En
Chang James N
Author_xml – fullname: Chang-Lin Joan-En
– fullname: Chang James N
– fullname: Jordan R. Scott
– fullname: Chang Chin-Ming
– fullname: Schiffman Rhett M
BookMark eNrjYmDJy89L5WTQcPXzcPRzdnVRcPL0dQzxDwjyDw5R8A_wCPFw9PH1dFYI9vcJDfH09-NhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGhmZGpgZGRqaOhsbEqQIApaonAw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2016250225A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2016250225A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:01:54 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2016250225A13
Notes Application Number: US201514876611
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160901&DB=EPODOC&CC=US&NR=2016250225A1
ParticipantIDs epo_espacenet_US2016250225A1
PublicationCentury 2000
PublicationDate 20160901
PublicationDateYYYYMMDD 2016-09-01
PublicationDate_xml – month: 09
  year: 2016
  text: 20160901
  day: 01
PublicationDecade 2010
PublicationYear 2016
RelatedCompanies Allergan, Inc
RelatedCompanies_xml – name: Allergan, Inc
Score 3.0529633
Snippet A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title ENHANCED BIMATOPROST OPHTHALMIC SOLUTION
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160901&DB=EPODOC&locale=&CC=US&NR=2016250225A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKeqbTsXLlIJSfCn2Etv6UKRXqqxNWVvZ21i6BgSZw1X8-57UTve0tyQHTpJDTr58uZwA3JLqUbfnjCu4GK0VojGizBjXFIRiXTNqYmpMEMUkNeOSvEweJj14X7-FaeOEfrfBEdGjKvT3pp2vl_-bWEF7t3J1z96w6OMpKpxA7tixZqqIb3LgOWFGA-rLvu-UuZyOWxmiPY5eF7nSDi6kLeEP4asn3qUsN0ElOoTdDPUtmiPo1YsB7Pvrv9cGsJd0R96Y7LxvdQx3YRqLv2QCyXtO3IJmY5oXEs3iInZHaE4pp6NSbDmdwE0UFn6sYJXTvx5Oy3yzfcYp9JH712cgGTazLE4qXWU64Spn5gxtqNkWRxpmz_g5DLdputguvoQDkf29MjWEfvP5VV8hxjbsujXND01CeoA
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq-KjakAJXoJ5rEk8BMmTVPOiSaS3kk2zIEgtNuLfdxJT7am3ZQf2Mezst9_uzCzALSkfZX1OmYCH0UogEiVCQZkkIBTLklIRVaINUQwj1c_J8_Rh2oP3dSxMmyf0u02OiBZVor3X7X69_L_EclrfytU9fcOqjycvMxy-Y8eSKiK-8Y5luEnsxDZv20ae8tGklSHa4-o1kSvt4CFba-zBfbWauJTlJqh4B7CbYHuL-hB61WIIA3v999oQ9sLuyRuLnfWtjuDOjfzmLxmHs8ahmcXJJE4zLk78zDcDVCeXxkHeXDkdw43nZrYvYJezvxnO8nRzfMoJ9JH7V6fAKTrVNEZKWaQyYSKjaoE6lHSNIQ3TC3YGo20tnW8XX8PAz8JgFoyjlwvYb0S_7lMj6NefX9Ul4m1Nr1o1_QA2-X1z
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ENHANCED+BIMATOPROST+OPHTHALMIC+SOLUTION&rft.inventor=Chang-Lin+Joan-En&rft.inventor=Chang+James+N&rft.inventor=Jordan+R.+Scott&rft.inventor=Chang+Chin-Ming&rft.inventor=Schiffman+Rhett+M&rft.date=2016-09-01&rft.externalDBID=A1&rft.externalDocID=US2016250225A1